Palmqvist, S., Warmenhoven, N., Anastasi, F., Pilotto, A., Janelidze, S., Tideman, P., Stomrud, E., Mattsson-Carlgren, N., Smith, R., Ossenkoppele, R., Tan, K., Dittrich, A., Skoog, I., Zetterberg, H., … Hansson, O. Plasma phospho-tau217 for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform, Nature Medicine, April 9, 2025, Read More
Horie, K., Salvadó, G., Koppisetti, R. K., Janelidze, S., Barthélemy, N. R., He, Y., Sato, C., Gordon, B. A., Jiang, H., Benzinger, T. L. S., Stomrud, E., Holtzman, D. M., Mattsson-Carlgren, N., Morris, J. C., Palmqvist, S., Ossenkoppele, R., Schindler, S. E., Hansson, O., & Bateman, R. J. Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer’s disease, Nature Medicine, March 31, 2025, Read More
Oh, H. S., Urey, D. Y., Karlsson, L., Zhu, Z., Shen, Y., ... Stevens, B., ... Zetterberg, H., ... Hansson, O., Cruchaga C., & Wyss-Coray, T. A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease, Nature Medicine, March 31, 2025, Read More
Ossenkoppele, R., Salvadó, G., Janelidze, S., Pichet Binette, A., Bali, D., ... Bateman R. J., ... Petersen, R. C, Jack, C. R., Jr, & Hansson, O. Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials, Nature Aging, March 28, 2025, Read More
Leuzy, A., Bollack, A., Pellegrino, D., Teunissen, C. E., La Joie, R., Rabinovici, G. D., Franzmeier, N., Johnson, K., Barkhof, F., Shaw, L. M., Arkhipenko, A., Schindler, S. E., Honig, L. S., Moscoso Rial, A., Schöll, M., Zetterberg, H., Blennow, K., Hansson, O., & Farrar, G. Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer’s disease, Alzheimer's & Dementia, March 5, 2025, Read More
Karlsson, L., Vogel, J., Arvidsson, I., Åström, K., Strandberg, O., Seidlitz, J., Bethlehem, R. A. I., Stomrud, E., Ossenkoppele, R., Ashton, N. J., Zetterberg, H., Blennow, K., Palmqvist, S., Smith, R., Janelidze, S., La Joie, R., Rabinovici, G. D., Binette, A. P., Mattsson-Carlgren, N., & Hansson, O. Machine learning prediction of tau-PET in Alzheimer’s disease using plasma, MRI, and clinical data, Alzheimer's & Dementia, February 22, 2025, Read More
Andersson, E., Lindblom, N., Janelidze, S., Salvadó, G., Gkanatsiou, E., Söderberg, L., Möller, C., Lannfelt, L., Ge, J., Hanrieder, J., Blennow, K., Deierborg, T., Mattsson-Carlgren, N., Zetterberg, H., Gouras, G., & Hansson, O. Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice, Nature Aging, February 12, 2025, Read More
Ashton, N. J., Keshavan, A., Brum, W. S., Andreasson, U., Arslan, B., … Hansson, O., ... Shaw, L. M., ... Zetterberg, H. The Alzheimer’s Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study, Alzheimer's & Dementia, February 5, 2025, Read More
Soto, C., Mollenhauer, B., Hansson, O., Kang, U. J., Alcalay, R. N., Standaert, D., Trenkwalder, C., Marek, K., Galasko, D., & Poston, K. Toward a biological definition of neuronal and glial synucleinopathies, Nature Medicine, January 30, 2025, Read More
Cicognola, C., Salvadó, G., Smith, R., Palmqvist, S., Stomrud, E., Betthauser, T., Johnson, S., Janelidze, S., Mattsson-Carlgren, N., Hansson, O., & Pichet Binette, A. APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta, Brain, January 16, 2025, Read More
Bellou, E., Kim, W., Leonenko, G., Tao, F., Simmonds, E., Wu, Y., Mattsson-Carlgren, N., Hansson, O., Nagle, M. W., Escott-Price, V., & Alzheimer’s Disease Neuroimaging Initiative Benchmarking Alzheimer’s disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies, Alzheimer's Research & Therapy, January 6, 2025, Read More
Mastrangelo, A., Mammana, A., Hall, S., Stomrud, E., Zenesini, C., Rossi, M., Janelidze, S., Ticca, A., Palmqvist, S., Magliocchetti, F., Baiardi, S., Mattsson-Carlgren, N., Hansson, O., & Parchi, P. Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum, Brain, December 17, 2024, Read More
Lindberg, O., Li, T. Q., Lind, C., Vestberg, S., Almkvist, O., Stiernstedt, M., Ericson, A., Bogdanovic, N., Hansson, O., Harper, L., Westman, E., Graff, C., Tsevis, T., Mannfolk, P., Fischer, H., Nilsonne, G., Petrovic, P., Nyberg, L., Wahlund, L. O., & Santillo, A. F. Altered Empathy Processing in Frontotemporal Dementia, JAMA Network Open, December 3, 2024, Read More
Fernandes Gomes, B., Kumar, A., Ashton, N. J., Hall, S., Stomrud, E., Smith, R., Zetterberg, H., Blennow, K., Mattsson-Carlgren, N., & Hansson, O. Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders, Brain Communications, November 19, 2024, Read More
2. Therriault, J., Janelidze, S., Benedet, A. L., Ashton, N. J., Arranz Martínez, J., Gonzalez-Escalante, A., Bellaver, B., Alcolea, D., Vrillon, A., Karim, H., Mielke, M. M., … Petersen, R. C., … Zetterberg, H., … Hansson, O., & Rosa-Neto, P. Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability, Nature Aging, November 12, 2024, Read More
Brolin, K. A., Bäckström, D., Wallenius, J., Gan-Or, Z., Puschmann, A., Hansson, O., & Swanberg, M. GBA1 T369M and Parkinson’s disease – Further evidence of a lack of association in the Swedish population, Parkinsonism & Related Disorders, October 31, 2024, Read More
Warmenhoven, N., Salvadó, G., Janelidze, S., Mattsson-Carlgren, N., Bali, D., Orduña Dolado, A., Kolb, H., Triana-Baltzer, G., Barthélemy, N. R., Schindler, S. E., Aschenbrenner, A. J., Raji, C. A., Benzinger, T. L. S., Morris, J. C., Ibanez, L., Timsina, J., Cruchaga, C., Bateman, R. J., Ashton, N., Arslan, B., … Hansson, O. A Comprehensive Head-to-Head Comparison of Key Plasma Phosphorylated Tau 217 Biomarker Tests, Brain, October 28, 2024, Read More
Borland, E., Mattson-Carlgren, N., Tideman, P., Alzheimer's Disease Neuroimaging Initiative, Stomrud, E., Hansson, O., & Palmqvist, S. Individualized, cross-validated prediction of future dementia using cognitive assessments in people with mild cognitive symptoms, Alzheimer's & Dementia, October 17, 2024, Read More
Svenningsson, A. L., Bocancea, D. I., Stomrud, E., van Loenhoud, A., Barkhof, F., Mattsson-Carlgren, N., Palmqvist, S., Hansson, O., & Ossenkoppele, R. Biological mechanisms of resilience to tau pathology in Alzheimer’s disease, Alzheimer's Research & Therapy, October 12, 2024, Read More
Freiburghaus, T., Pawlik, D., Oliveira Hauer, K., Ossenkoppele, R., Strandberg, O., Leuzy, A., Rittmo, J., Tremblay, C., Serrano, G. E., Pontecorvo, M. J., Beach, T. G., Smith, R., & Hansson, O. Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions, Acta Neuropathologica, September 19, 2024, Read More
Wuestefeld, A., Pichet Binette, A., van Westen, D., Strandberg, O., Stomrud, E., Mattsson-Carlgren, N., Janelidze, S., Smith, R., Palmqvist, S., Baumeister, H., Berron, D., Yushkevich, P. A., Hansson, O., Spotorno, N., & Wisse, L. E. M. Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease, Alzheimer's Research & Therapy, September 16, 2024, Read More
Collij, L. E., Mastenbroek, S. E., Mattsson-Carlgren, N., Strandberg, O., Smith, R., Janelidze, S., Palmqvist, S., Ossenkoppele, R., & Hansson, O. Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease, Nature Communications, September 14, 2024, Read More
Pichet Binette, A., Mammana, A., Wisse, L., Rossi, M., Strandberg, O., Smith, R., Mattsson-Carlgren, N., Janelidze, S., Palmqvist, S., ADNI, Ticca, A., Stomrud, E., Parchi, P., & Hansson, O. Associations between misfolded alpha-synuclein aggregates and Alzheimer’s disease pathology in vivo, Allheimer's & Dementia, September 11, 2024, Read More
Pichet Binette, A., Gaiteri, C., Wennström, M., Kumar, A., Hristovska, I., Spotorno, N., Salvadó, G., Strandberg, O., Mathys, H., Tsai, L. H., Palmqvist, S., Mattsson-Carlgren, N., Janelidze, S., Stomrud, E., Vogel, J. W., & Hansson, O. Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies, Nature Neuroscience, August 26, 2024, Read More
Palmqvist, S., Tideman, P., Mattsson-Carlgren, N., Schindler, S. E., Smith, R., Ossenkoppele, R., Calling, S., West, T., Monane, M., Verghese, P. B., Braunstein, J. B., Blennow, K., Janelidze, S., Stomrud, E., Salvadó, G., & Hansson, O. Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care, JAMA, July 28, 2024, Read More
Wisse, L. E. M., Spotorno, N., Rossi, M., Grothe, M. J., Mammana, A., Tideman, P., Baiardi, S., Strandberg, O., Ticca, A., van Westen, D., Mattsson-Carlgren, N., Palmqvist, S., Stomrud, E., Parchi, P., Hansson, O., & Alzheimer’s Disease Neuroimaging Initiative MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population, JAMA Neurology, July 28, 2024, Read More
Janelidze, S., Barthélemy, N. R., Salvadó, G., Schindler, S. E., Palmqvist, S., Mattsson-Carlgren, N., Braunstein, J. B., Ovod, V., Bollinger, J. G., He, Y., Li, Y., Raji, C. A., Morris, J. C., Holtzman, D. M., Ashton, N. J., Blennow, K., Stomrud, E., Bateman, R. J., & Hansson, O. Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment, JAMA Neurology, July 28, 2024, Read More
Leuzy, A., Raket, L. L., Villemagne, V. L., Klein, G., Tonietto, M., … Petersen, R. C., ... Ossenkoppele, R., ... Hansson, O., ... Doré, V. Harmonizing tau positron emission tomography in Alzheimer’s disease: The CenTauR scale and the joint propagation model, Alzheimer's & Dementia, July 23. 2024, Read More
Howe, M. D., Britton, K. J., Joyce, H. E., Menard, W., Emrani, S., Kunicki, Z. J., Faust, M. A., Dawson, B. C., Riddle, M. C., Huey, E. D., Janelidze, S., Hansson, O., & Salloway, S. P. Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease, Alzheimer's Research & Therapy, July 6, 2024, Read More
Lerch, O., Ferreira, D., Stomrud, E., van Westen, D., Tideman, P., Palmqvist, S., Mattsson-Carlgren, N., Hort, J., Hansson, O., & Westman, E. Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns, Alzheimer's Research & Therapy, July 5, 2024, Read More
Aschenbrenner, A., Hassenstab, J.J., Schindler, S.E., Janelidze, S., Hansson, O., Morris, J. C., Grober, E. Free Recall Outperforms Story Recall in Associations with Plasma Biomarkers in Preclinical Alzheimer Disease, The Journal of Prevention of Alzheimer's Disease, July 2, 2024, Read More
Glans, I., Nägga, K., Gustavsson, A. M., Stomrud, E., Nilsson, P. M., Melander, O., Hansson, O., & Palmqvist, S. Associations of modifiable and non-modifiable risk factors with cognitive functions – a prospective, population-based, 17 years follow-up study of 3,229 individuals, Alzheimer's Research & Therapy, June 26, 2024, Read More
Orduña Dolado, A., Stomrud, E., Ashton, N. J., Nilsson, J., Quijano-Rubio, C., Jethwa, A., Brum, W. S., Brinkmalm Westman, A., Zetterberg, H., Blennow, K., Janelidze, S., & Hansson, O. Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’ disease biomarkers, Alzheimer's Research & Therapy, June 22, 2024, Read More
Baiardi, S., Hansson, O., Levin, J., & Parchi, P. In vivo detection of Alzheimer’s and Lewy body disease concurrence: Clinical implications and future perspectives, Alzheimer's & Dementia, June 21, 2024, Read More
Harper, L., Strandberg, O., Spotorno, N., Nilsson, M., Lindberg, O., Hansson, O., & Santillo, A. F. Structural and functional connectivity associations with anterior cingulate sulcal variability, Brain Structure & Function, 6/20/2024, Read More
Soleimani-Meigooni, D. N., Smith, R., Provost, K., Lesman-Segev, O. H., Allen, I. E., Chen, M. K., Cho, H., Edwards, L., Janelidze, S., La Joie, R., Mundada, N., Ossenkoppele, R., Stomrud, E., Strandberg, O., Strom, A., Boxer, A. L., Dage, J. L., Gorno-Tempini, M. L., Kramer, J. H., Miller, B. L., …, Hansson, O., Rabinovici, G. D. Head-to-Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study, Annals of Neurology, June 18, 2024, Read More
Mastenbroek, S. E., Vogel, J. W., Collij, L. E., Serrano, G. E., Tremblay, C., Young, A. L., Arce, R. A., Shill, H. A., Driver-Dunckley, E. D., Mehta, S. H., Belden, C. M., Atri, A., Choudhury, P., Barkhof, F., Adler, C. H., Ossenkoppele, R., Beach, T. G., & Hansson, O. Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology, Nature Communications, June 15, 2024, Read More
Berron, D., Olsson, E., Andersson, F., Janelidze, S., Tideman, P., Düzel, E., Palmqvist, S., Stomrud, E., & Hansson, O. Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer’s disease, Alzheimer's & Dementia, June 12, 2024, Read More
Schindler, S. E., Galasko, D., Pereira, A. C., Rabinovici, G. D., Salloway, S., Suárez-Calvet, M., Khachaturian, A. S., Mielke, M. M., Udeh-Momoh, C., Weiss, J., Batrla, R., Bozeat, S., Dwyer, J. R., Holzapfel, D., Jones, D. R., Murray, J. F., Partrick, K. A., Scholler, E., Vradenburg, G., Young, D., … Hansson, O. Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease, Nature Reviews Neurology, June 12, 2024, Read More
Groot, C., Smith, R., Collij, L. E., Mastenbroek, S. E., Stomrud, E., Binette, A. P., Leuzy, A., Palmqvist, S., Mattsson-Carlgren, N., Strandberg, O., Cho, H., Lyoo, C. H., Frisoni, G. B., Peretti, D. E., Garibotto, V., La Joie, R., Soleimani-Meigooni, D. N., Rabinovici, G., Ossenkoppele, R., & Hansson, O. Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment, JAMA Neurology, June 10, 2024, Read More
Niimi, Y., Janelidze, S., Sato, K., Tomita, N., Tsukamoto, T., … Hansson, O., Iwatsubo, T. Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly, Alzheimer's Research & Therapy, May 23, 2024, Read More
Karlsson, L., Vogel, J., Arvidsson, I., Åström, K., Janelidze, S., Blennow, K., Palmqvist, S., Stomrud, E., Mattsson-Carlgren, N., & Hansson, O. Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases, Nature Communications, May 1, 2024, Read More
Baumeister, H., Vogel, J. W., Insel, P. S., Kleineidam, L., Wolfsgruber, S., … Hansson, O., Berron, D. A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings, Brain Communications, April 24, 2024, Read More
Yu, L., Wang, T., Hansson, O., Janelidze, S., Lamar, M., Arfanakis, K., Bennett, D. A., Schneider, J. A., & Boyle, P. A. Plasma P-Tau217 for Predicting Alzheimer Dementia Among Community-Dwelling Older Adults, Neurology, Clinical practice, April 15, 2024, Read More
Ahmadi, K., Pereira, J. B., Westen, D. V., Pasternak, O., Zhang, F., Nilsson, M., Stomrud, E., Spotorno, N., & Hansson, O. Fixel-based analysis reveals tau-related white matter changes in early stages of Alzheimer’s disease, The Journal of Neuroscience, April 2, 2024, Read More
Salvadó, G., Horie, K., Barthélemy, N. R., Vogel, J. W., Pichet Binette, A., Chen, C. D., Aschenbrenner, A. J., Gordon, B. A., Benzinger, T. L. S., Holtzman, D. M., Morris, J. C., Palmqvist, S., Stomrud, E., Janelidze, S., Ossenkoppele, R., Schindler, S. E., Bateman, R. J., & Hansson, O. Disease staging of Alzheimer’s disease using a CSF-based biomarker model, Nature Aging, March 21, 2024, Read More
Arvidsson, I., Strandberg, O., Palmqvist, S., Stomrud, E., Cullen, N., Janelidze, S., Tideman, P., Heyden, A., Åström, K., Hansson, O., & Mattsson-Carlgren, N. Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer’s disease in patients with mild cognitive symptoms, Alzheimer's Research & Therapy, March 19, 2024, Read More
Brum, W. S., Cullen, N. C., Therriault, J., Janelidze, S., Rahmouni, N., Stevenson, J., Servaes, S., Benedet, A. L., Zimmer, E. R., Stomrud, E., Palmqvist, S., Zetterberg, H., Frisoni, G. B., Ashton, N. J., Blennow, K., Mattsson-Carlgren, N., Rosa-Neto, P., & Hansson, O. A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings, Nature Communications, March 14, 2024, Read More
Barthélemy, N. R., Salvadó, G., Schindler, S., He, Y., Janelidze, S., Collij, L. E., Saef, B., Henson, R. L., Chen, C. D., Gordon, B. A., Li, Y., La Joie, R., Benzinger, T. L. S., Morris, J. C., Mattsson-Carlgren, N., Palmqvist, S., Ossenkoppele, R., Rabinovici, G. D., Stomrud, E., Bateman, R. J. & Hansson, O. Highly Accurate Blood Test for Alzheimer’s Disease Comparable or Superior to Clinical CSF Tests, Nature Medicine, February 21, 2024, Read More
Wennström, M., Schultz, N., Gallardo, P. M., The Netherlands Brain Bank, Serrano, G. E., Beach, T. G., Bose, S., & Hansson, O. The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer’s Disease Pathology, Cells, February 11, 2024, Read More
Bali, D., Hansson, O., & Janelidze, S. Effects of certain pre-analytical factors on the performance of plasma phospho-tau217, Alzheimer's Research & Therapy, February 8, 2024, Read More
Nilsson, J., Pichet Binette, A., Palmqvist, S., Brum, W. S., Janelidze, S., Ashton, N. J., Spotorno, N., Stomrud, E., Gobom, J., Zetterberg, H., Brinkmalm, A., Blennow, K., & Hansson, O. Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases, Brain, February 7, 2024, Read More
Spotorno, N., Najac, C., Strandberg, O., Stomrud, E., van Westen, D., Nilsson, M., Ronen, I., & Hansson, O. Diffusion weighted magnetic resonance spectroscopy revealed neuronal specific microstructural alterations in Alzheimer’s disease, Brain Communications, February 1, 2024, Read More
Young, A. L., Vogel, J. W., Robinson, J. L., McMillan, C. T., Ossenkoppele, R., Wolk, D. A., Irwin, D. J., Elman, L., Grossman, M., Lee, V. M., Lee, E. B., & Hansson, O. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies, Brain, May 8, 2023, Read More
Coomans, E. M., van Westen, D., Pichet Binette, A., Strandberg, O., Spotorno, N., Serrano, G. E., Beach, T. G., Palmqvist, S., Stomrud, E., Ossenkoppele, R., & Hansson, O. Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation, Brain, September 18, 2023, Read More
Bocancea, D. I., Svenningsson, A. L., van Loenhoud, A. C., Groot, C., Barkhof, F., Strandberg, O., Smith, R., Alzheimer’s Disease Neuroimaging Initiative, La Joie, R., Rosen, H. J., Pontecorvo, M. J., Rabinovici, G. D., van der Flier, W. M., Hansson, O., & Ossenkoppele, R. Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis, Brain, March 27, 2023, Read More
Zheng, L., Rubinski, A., Denecke, J., Luan, Y., Smith, R., Strandberg, O., Stomrud, E., Ossenkoppele, R., Svaldi, D. O., Higgins, I. A., Shcherbinin, S., Pontecorvo, M. J., Hansson, O., Franzmeier, N., Ewers, M., & Alzheimer's Disease Neuroimaging Initiative Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease, Annals of Neurology, October 14, 2023, Read More
Pereira, J. B., Kumar, A., Hall, S., Palmqvist, S., Stomrud, E., Bali, D., Parchi, P., Mattsson-Carlgren, N., Janelidze, S., & Hansson, O. DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease, Nature Aging, September 18, 2023, Read More
Oeckl, P., Janelidze, S., Halbgebauer, S., Stomrud, E., Palmqvist, S., Otto, M., & Hansson, O. Higher plasma beta-synuclein indicates early synaptic degeneration in Alzheimer’s disease, Alzheimer's & Dementia, April 27, 2023, Read More
Wuestefeld, A., Pichet Binette, A., Berron, D., Spotorno, N., van Westen, D., Stomrud, E., Mattsson-Carlgren, N., Str|berg, O., Smith, R., Palmqvist, S., Glenn, T., Moes, S., Honer, M., Arfanakis, K., Barnes, L. L., Bennett, D. A., Schneider, J. A., Wisse, L. E. M., & Hansson, O. Age-related and amyloid-beta-independent tau deposition and its downstream effects, Brain, April 21, 2023, Read More
Spotorno, N., Strandberg, O., Stomrud, E., Janelidze, S., Blennow, K., Nilsson, M., van Westen, D., & Hansson, O. Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer’s disease, Brain, December 21, 2023, Read More
Harper, L., de Boer, S., Lindberg, O., Lätt, J., Cullen, N., Clark, L., Irwin, D., Massimo, L., Grossman, M., Hansson, O., Pijnenburg, Y., McMillan, C. T., & Santillo, A. F. Anterior cingulate sulcation is associated with onset and survival in frontotemporal dementia, Brain Communications, October 10, 2023, Read More
Kuchcinski, G., Rumetshofer, T., Zervides, K. A., Lopes, R., Gautherot, M., Pruvo, J. P., Bengtsson, A. A., Hansson, O., Jönsen, A., & Sundgren, P. C. M. MRI BrainAGE demonstrates increased brain aging in systemic lupus erythematosus patients, Frontiers in Aging Neuroscience, October 20, 2023, Read More
Pocevičiūtė, D., Roth, B., Schultz, N., Nuñez-Diaz, C., Janelidze, S., The Netherl|s Brain Bank, Olofsson, A., Hansson, O., & Wennström, M. Plasma IAPP-Autoantibody Levels in Alzheimer’s Disease Patients Are Affected by APOE4 Status, International Journal of Molecular Sciences, February 14, 2023, Read More
Brum, W. S., Cullen, N. C., Janelidze, S., Ashton, N. J., Zimmer, E. R., Therriault, J., Benedet, A. L., Rahmouni, N., Tissot, C., Stevenson, J., Servaes, S., Triana-Baltzer, G., Kolb, H. C., Palmqvist, S., Stomrud, E., Rosa-Neto, P., Blennow, K., & Hansson, O. A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases, Nature Aging, August 31, 2023, Read More
Smith, R., Capotosti, F., Schain, M., Ohlsson, … Hansson, O. The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases, Nature Communications, October 27, 2023, Read More
Palmqvist, S., Rossi, M., Hall, S., Quadalti, C., Mattsson-Carlgren, N., Dellavalle, S., Tideman, P., Pereira, J. B., Nilsson, M. H., Mammana, A., Janelidze, S., Baiardi, S., Stomrud, E., Parchi, P., & Hansson, O. Cognitive effects of Lewy body pathology in clinically unimpaired individuals, Nature Medicine, July 18, 2023, Read More
Quadalti, C., Palmqvist, S., Hall, S., Rossi, M., Mammana, A., Janelidze, S., Dellavalle, S., Mattsson-Carlgren, N., Baiardi, S., Stomrud, E., Hansson, O., & Parchi, P. Clinical effects of Lewy body pathology in cognitively impaired individuals, Nature Medicine, July 18, 2023, Read More
Van Egroo, M., Riphagen, J. M., Ashton, N. J., Janelidze, S., Sperling, R. A., Johnson, K. A., Yang, H. S., Bennett, D. A., Blennow, K., Hansson, O., Zetterberg, H., & Jacobs, H. I. L. Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau, Molecular Psychiatry, April 5, 2023, Read More
Hansson, O., Blennow, K., Zetterberg, H., & Dage, J. Blood biomarkers for Alzheimer’s disease in clinical practice and trials, Nature Aging, May 18, 2023, Read More
Brand, A. L., Lawler, P. E., Bollinger, J. G., Li, Y., Schindler, S. E., Li, M., Lopez, S., Ovod, V., Nakamura, A., Shaw, L. M., Zetterberg, H., Hansson, O., & Bateman, R. J. The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review, Alzheimer's Research & Therapy, December 27, 2022, Read More
Barthélemy, N. R., Saef, B., Li, Y., Gordon, B. A., He, Y., Horie, K., Stomrud, E., Salvadó, G., Janelidze, S., Sato, C., Ovod, V., Henson, R. L., Fagan, A. M., Benzinger, T. L. S., Xiong, C., Morris, J. C., Hansson, O., Bateman, R. J., & Schindler, S. E. CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease, Nature Aging, March 13, 2023, Read More
Horie, K., Salvadó, G., Barthélemy, N. R., Janelidze, S., Li, Y., He, Y., Saef, B., Chen, C. D., Jiang, H., Strandberg, O., Pichet Binette, A., Palmqvist, S., Sato, C., Sachdev, P., Koyama, A., Gordon, B. A., Benzinger, T. L. S., Holtzman, D. M., Morris, J. C., Mattsson-Carlgren, N., … Bateman, R. J. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease, Nature Medicine, July 13, 2023, Read More
Brum, W. S., Docherty, K. F., Ashton, N. J., Zetterberg, H., Hansson, O., McMurray, J. J. V., & Blennow, K. Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial, JAMA Neurology, December 18, 2023, Read More
Mattsson-Carlgren, N., Collij, L. E., Stomrud, E., Pichet Binette, A., Ossenkoppele, R., Smith, R., Karlsson, L., Lantero-Rodriguez, J., Snellman, A., Strandberg, O., Palmqvist, S., Ashton, N. J., Blennow, K., Janelidze, S., & Hansson, O. Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies, JAMA Neurology, December 4, 2023, Read More
Smith, R., Hägerström, D., Pawlik, D., Klein, G., Jögi, J., Ohlsson, T., Stomrud, E., & Hansson, O. Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms, JAMA Neurology, May 22, 2023, Read More
